M3554

· EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M3554, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Anti-GD2 ADC M3554 in Advanced Solid Tumors [Phase 1]